These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25402286)

  • 61. Vancomycin-induced acute kidney injury after liver transplantation.
    Shi XP; Lao DH; Xu Q; Zhang M; Lu YH; Gong Y; Wang T
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):403-406. PubMed ID: 33879407
    [No Abstract]   [Full Text] [Related]  

  • 62. Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
    Davies SW; Efird JT; Guidry CA; Dietch ZC; Willis RN; Shah PM; Sawyer RG
    Surg Infect (Larchmt); 2016 Feb; 17(1):38-47. PubMed ID: 26484854
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vancomycin Therapeutic Targets and Nephrotoxicity in Critically Ill Children With Cancer.
    Seixas GT; Araujo OR; Silva DC; Arduini RG; Petrilli AS
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):e56-62. PubMed ID: 26558810
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Establishment of an AUC
    Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.
    Pan K; Ma L; Xiang Q; Li X; Li H; Zhou Y; Yang L; Cui Y
    PLoS One; 2017; 12(4):e0175688. PubMed ID: 28426688
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute Kidney Injury With Tobramycin-Impregnated Bone Cement Spacers in Prosthetic Joint Infections.
    Aeng ES; Shalansky KF; Lau TT; Zalunardo N; Li G; Bowie WR; Duncan CP
    Ann Pharmacother; 2015 Nov; 49(11):1207-13. PubMed ID: 26269097
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
    Anderson CW; Cazares KS; Lustik MB; Patel SM; Denunzio TM
    Mil Med; 2017 Sep; 182(9):e1773-e1778. PubMed ID: 28885936
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.
    Hong LT; Goolsby TA; Sherman DS; Mueller SW; Reynolds P; Cava L; Neumann R; Kiser TH
    J Crit Care; 2015 Oct; 30(5):1153.e1-6. PubMed ID: 26239323
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
    Malacarne P; Bergamasco S; Donadio C
    Chemotherapy; 2006; 52(4):178-84. PubMed ID: 16691027
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of a Pharmacist-Initiated Vancomycin Monitoring Program.
    Smith AP; Millares-Sipin CA; James M; Cohen H
    Consult Pharm; 2016 Sep; 31(9):505-10. PubMed ID: 27636875
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Commentary on "incidence and predictors of vancomycin-associated nephrotoxicity".
    Bookstaver PB; Justo JA
    South Med J; 2014 Jun; 107(6):389-90. PubMed ID: 24945177
    [No Abstract]   [Full Text] [Related]  

  • 72. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring.
    Han HK; An H; Shin KH; Shin D; Lee SH; Kim JH; Cho SH; Kang HR; Jang IJ; Yu KS; Lim KS
    Ther Drug Monit; 2014 Oct; 36(5):606-11. PubMed ID: 24577126
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans.
    Prabaker KK; Tran TP; Pratummas T; Goetz MB; Graber CJ
    J Hosp Med; 2012 Feb; 7(2):91-7. PubMed ID: 22086511
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.
    Kim T; Kandiah S; Patel M; Rab S; Wong J; Xue W; Easley K; Anderson AM
    BMC Res Notes; 2015 Oct; 8():579. PubMed ID: 26476979
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
    Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
    Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute Kidney Injury in Patients Treated with IV Beta-Lactam/Beta-Lactamase Inhibitor Combinations.
    Rutter WC; Burgess DS
    Pharmacotherapy; 2017 May; 37(5):593-598. PubMed ID: 28247443
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vancomycin toxicity in neonates: a review of the evidence.
    Lestner JM; Hill LF; Heath PT; Sharland M
    Curr Opin Infect Dis; 2016 Jun; 29(3):237-47. PubMed ID: 26895572
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nephrotoxicity of vancomycin in patients with normal serum creatinine.
    Colares VS; Oliveira RB; Abdulkader RC
    Nephrol Dial Transplant; 2006 Dec; 21(12):3608. PubMed ID: 16861241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.